DOCSLIB.ORG

Fig1-13Tab1-5.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Fig1-13Tab1-5.Pdf Supplementary Information Promoter hypomethylation of EpCAM-regulated bone morphogenetic protein genes in advanced endometrial cancer Ya-Ting Hsu, Fei Gu, Yi-Wen Huang, Joseph Liu, Jianhua Ruan, Rui-Lan Huang, Chiou-Miin Wang, Chun-Liang Chen, Rohit R. Jadhav, Hung-Cheng Lai, David G. Mutch, Paul J. Goodfellow, Ian M. Thompson, Nameer B. Kirma, and Tim Hui-Ming Huang Tables of contents Page Table of contents 2 Supplementary Methods 4 Supplementary Figure S1. Summarized sequencing reads and coverage of MBDCap-seq 8 Supplementary Figure S2. Reproducibility test of MBDCap-seq 10 Supplementary Figure S3. Validation of MBDCap-seq by MassARRAY analysis 11 Supplementary Figure S4. Distribution of differentially methylated regions (DMRs) in endometrial tumors relative to normal control 12 Supplementary Figure S5. Network analysis of differential methylation loci by using Steiner-tree analysis 13 Supplementary Figure S6. DNA methylation distribution in early and late stage of the TCGA endometrial cancer cohort 14 Supplementary Figure S7. Relative expression of BMP genes with EGF treatment in the presence or absence of PI3K/AKT and Raf (MAPK) inhibitors in endometrial cancer cells 15 Supplementary Figure S8. Induction of invasion by EGF in AN3CA and HEC1A cell lines 16 Supplementary Figure S9. Knockdown expression of BMP4 and BMP7 in RL95-2 cells 17 Supplementary Figure S10. Relative expression of BMPs and BMPRs in normal endometrial cell and endometrial cancer cell lines 18 Supplementary Figure S11. Microfluidics-based PCR analysis of EMT gene panel in RL95-2 cells with or without EGF treatment 19 Supplementary Figure S12. Knockdown expression of EpCAM by different shRNA sequences in RL95-2 cells 20 Supplementary Figure S13. Proposed model for EpICD mediated regulation of BMP genes by EGF 21 2 Supplementary Table 1. Characteristics of endometrial cancer patients 22 Supplemental Table 2. Summary of sequencing reads in endometrial tumors an normal controls 23 Supplementary Table 3. Differentially methylated promoter CpG islands in recurrent relative to non-recurrent tumors 26 Supplementary Table 4. List of primer sequences 55 Supplementary Table 5. List of siRNA and shRNA sequences 59 Supplementary References 60 3 Supplementary Methods MassARRAY analysis To quantify methylation levels of CpG islands in clinical samples, the high-throughput MassARRAY platform (Sequenom) was carried out as described previously (Huang et al. 2009). Briefly, DNA was bisulfite-converted and subjected to PCR and base-specific cleavage. The cleaved DNA was analyzed by MALDI-TOF mass spectrometry. Methylation data of HAAO, RXFP3, and miR-129-2 CpG islands were published previously (Huang et al. 2009, 2010). Definition of methylation types All known transcripts were divided into 1) promoter CpG island located within 2-kb up- or downstream of its TSS and 2) promoter non-CpG island located within 2-kb windows of its TSS. Other regions were defined as intragenic CpG island located after 2-kb downstream of a TSS and before 3’-UTR and intergenic CpG island located before >2-kb upstream of a TSS or after 3’-UTR. Bioinformatics analysis Sequence reads mapped to unique genome locations were normalized to the sum of unique reads and other reads (e.g., repeat sequences). Unique reads were collected after normalization and directionally extended to 200-bp. The methylation level of each bin size was calculated by accumulating the reads number if the read was located in the bin. Linear normalization method based on the unique mapped read number was used to normalize methylation enrichment: , , /^ 4 th Where , is the normalized read number of the i bin, and , is the uniquely mapped th read number of the i bin, is the total uniquely mapped reads number. “INT” function rounds the element (in the parenthesis) to the nearest integers towards minus infinity, “^” means the power operator. For two groups A and B, the sample number is for group A, and for group B. For a given region R (which includes m bin size, and start at the sth bin), the average methylation level is ∑ , , , ,,…, for group A or B (if is A or B). In equation 2, , means the average methylation level of group at region , , is the methylation levels of each sample of group at region . We then used paired t-test to compare if the methylation level of the region was significantly different between those two groups. Differentially methylated loci between endometrial carcinoma samples and normal controls and between recurrent and non-recurrent tumor groups were analyzed by the above algorithm. Network analysis of differential methylation loci by using Steiner-tree analysis Differentially methylated loci were mapped to a human protein-protein interaction (PPI) network (Wu G, Feng X, & Stein L. 2010) to identify a small number of connector genes that can link these loci into a singly connected sub-network. These connector genes were identified with the well-known Steiner-tree algorithm (Huang SS & Fraenkel E. 2009). Formally, the Steiner- tree for an edge-weighted graph G = (V, E, W) and a subset of vertices S ⊆V is a minimum- weight connected tree T, with vertices U⊆V and edges D⊆E that spans all vertices in S. Here the vertices in S are known as terminal vertices and UnS as Steiner vertices. For an un- weighted graph G, the problem then becomes to find the minimum number of vertices that can connect all the vertices in R through a tree in G. The Steiner tree problem is NP-hard and 5 therefore a polynomial-time 2-approximation shortest path heuristic algorithm of Steiner-tree problem was used (Huang SS & Fraenkel E. 2009). To de-noise and to increase the probability of covering all core members in the pathways and alternative functional links between pathways, a simple randomized algorithm was designed to obtain multiple Steiner trees with suboptimal quality (i.e., slightly more connector genes) (Huang SS & Fraenkel E. 2009). This procedure was repeated multiple times with different random weights, until the total number of unique Steiner vertices converges approximately. In this work, the rate of new coming Steiner vertices reduced significantly after 10 iterations. The Steiner vertices in the 10 Steiner trees were pooled to obtain connector genes, and a sub-network containing connectors and differentially methylated loci was extracted from the PPI network. The connectors were further analyzed for enriched KEGG pathways using the online functional annotation tool DAVID (Huang de W, Sherman BT, Lempicki RA. 2009). DNA methylation distribution and survival analysis of BMP genes in the TCGA cohort All TCGA cohort array and clinical data were downloaded from the TCGA website (http://www.cancergenome.nih.gov/) and the TCGA endometrial data snapshot website (http://23.23.224.116/ucec_tcga/). To compare DNA methylation levels in recurrent/progression group with non-recurrent group, we filtered patients who have clinical information provided with recurrent/progression status, survival and DNA methylation data as the final cohort for analysis. In this cohort, 39 patients showed primary tumors with recurrence/progression and 193 patients were non-recurrent. Recurrent rate is 16 % (39/232=0.16). We further filtered the DNA methylation data by only looking at probes located in the 2-kb region around transcription start site (TSS) with CpG island annotation or differential methylation regions identified in BMP2, BMP3, BMP4 and BMP7 in our own cohort. For progression free survival analysis, 15 percentile was used as the cutoff to dichotomize the DNA methylation level into high (n=197) and low methylation (n=35) in each of BMPs probe. The low methylation of BMP4 and BMP7 6 showed a significant association with poor survival (Both of P < 0.01) by Kaplan–Meier curve analysis. For the methylation distribution in disease stage, stage I and stage II were combined as early stage (n=153) and stage III and IV were designated as late stage (n=33). The methylation distributions of BMP genes were illustrated as representative figures showing one probe, corresponding to the same CpG site shown in Fig. 3A. lower panel. PI3K/AKT and Raf (MAPK) inhibitors treatment RL95-2 cells were grown in DMEM culture medium (Life Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) and 1% Penicillin/Streptomycin (Life Technologies) at 37oC. One day before the treatment, media was changed to DMEM supplemented with 10% charcoal stripped-heat inactivated (CSHI) FBS for treatments. PI3K/AKT inhibitor LY 294002 (4 uM, EMD Chemicals, Germany) and Raf (MAPK) inhibitor PLX-4720 (2uM, Selleck Chemicals, Houston, TX) were added with or without EGF (10 ng/mL, Peprotech, Rocky Hill, NJ) for 72 hours. RNA was then isolated using Direct-zolTM RNA MiniPrep according to the manufacturer’s manual (Zymo Research, Irvine, CA). 7 B Promoter region Whole genome (2-kb centered on TSS) (1-kb sliding window) (n=21,853) (n=3,022,656) No 1 No 1 coverage 2-4 coverage 2-4 ≥50 5-9 ≥50 Endometrial normal 5-9 25-49 25-49 10-24 10-24 No coverage 1 No 1 2-4 2-4 coverage ≥50 ≥50 Endometrial tumor 5-9 5-9 25-49 25-49 10-24 10-24 Supplementary Figure S1. Summarized sequencing reads coverage of MBDCap-seq. (A) Summarized sequencing reads in normal samples (n=10) and endometrial tumors (n=67). Each bar represents an individual sample. Blue and red bars indicate unique reads and repeat sequences, respectively. (B) Genomic coverage was quantified by the number of DNA methylation measurements that overlap with gene promoters and a 1-kb tiling of the genome. 8 Each read was extended to the mean length obtained during size selection. The number of measurements was equal to the number of unique sequencing reads that fall inside each region. Promoter regions were based on the human reference sequence (hg18; NCBI Build 36.1) and covered 1-kb upstream and 1-kb downstream of the annotated transcription start site.
Load more

Recommended publications
  • THE ROLE of HOMEODOMAIN TRANSCRIPTION FACTOR IRX5 in CARDIAC CONTRACTILITY and HYPERTROPHIC RESPONSE by © COPYRIGHT by KYOUNG H
    THE ROLE OF HOMEODOMAIN TRANSCRIPTION FACTOR IRX5 IN CARDIAC CONTRACTILITY AND HYPERTROPHIC RESPONSE By KYOUNG HAN KIM A THESIS SUBMITTED IN CONFORMITY WITH THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY GRADUATE DEPARTMENT OF PHYSIOLOGY UNIVERSITY OF TORONTO © COPYRIGHT BY KYOUNG HAN KIM (2011) THE ROLE OF HOMEODOMAIN TRANSCRIPTION FACTOR IRX5 IN CARDIAC CONTRACTILITY AND HYPERTROPHIC RESPONSE KYOUNG HAN KIM DOCTOR OF PHILOSOPHY GRADUATE DEPARTMENT OF PHYSIOLOGY UNIVERSITY OF TORONTO 2011 ABSTRACT Irx5 is a homeodomain transcription factor that negatively regulates cardiac fast transient + outward K currents (Ito,f) via the KV4.2 gene and is thereby a major determinant of the transmural repolarization gradient. While Ito,f is invariably reduced in heart disease and changes in Ito,f can modulate both cardiac contractility and hypertrophy, less is known about a functional role of Irx5, and its relationship with Ito,f, in the normal and diseased heart. Here I show that Irx5 plays crucial roles in the regulation of cardiac contractility and proper adaptive hypertrophy. Specifically, Irx5-deficient (Irx5-/-) hearts had reduced cardiac contractility and lacked the normal regional difference in excitation-contraction with decreased action potential duration, Ca2+ transients and myocyte shortening in sub-endocardial, but not sub-epicardial, myocytes. In addition, Irx5-/- mice showed less cardiac hypertrophy, but increased interstitial fibrosis and greater contractility impairment following pressure overload. A defect in hypertrophic responses in Irx5-/- myocardium was confirmed in cultured neonatal mouse ventricular myocytes, exposed to norepinephrine while being restored with Irx5 replacement. Interestingly, studies using mice ii -/- virtually lacking Ito,f (i.e. KV4.2-deficient) showed that reduced contractility in Irx5 mice was completely restored by loss of KV4.2, whereas hypertrophic responses to pressure-overload in hearts remained impaired when both Irx5 and Ito,f were absent.
    [Show full text]
  • 1 Evidence for Gliadin Antibodies As Causative Agents in Schizophrenia
    1 Evidence for gliadin antibodies as causative agents in schizophrenia. C.J.Carter PolygenicPathways, 20 Upper Maze Hill, Saint-Leonard’s on Sea, East Sussex, TN37 0LG [email protected] Tel: 0044 (0)1424 422201 I have no fax Abstract Antibodies to gliadin, a component of gluten, have frequently been reported in schizophrenia patients, and in some cases remission has been noted following the instigation of a gluten free diet. Gliadin is a highly immunogenic protein, and B cell epitopes along its entire immunogenic length are homologous to the products of numerous proteins relevant to schizophrenia (p = 0.012 to 3e-25). These include members of the DISC1 interactome, of glutamate, dopamine and neuregulin signalling networks, and of pathways involved in plasticity, dendritic growth or myelination. Antibodies to gliadin are likely to cross react with these key proteins, as has already been observed with synapsin 1 and calreticulin. Gliadin may thus be a causative agent in schizophrenia, under certain genetic and immunological conditions, producing its effects via antibody mediated knockdown of multiple proteins relevant to the disease process. Because of such homology, an autoimmune response may be sustained by the human antigens that resemble gliadin itself, a scenario supported by many reports of immune activation both in the brain and in lymphocytes in schizophrenia. Gluten free diets and removal of such antibodies may be of therapeutic benefit in certain cases of schizophrenia. 2 Introduction A number of studies from China, Norway, and the USA have reported the presence of gliadin antibodies in schizophrenia 1-5. Gliadin is a component of gluten, intolerance to which is implicated in coeliac disease 6.
    [Show full text]
  • Core Transcriptional Regulatory Circuitries in Cancer
    Oncogene (2020) 39:6633–6646 https://doi.org/10.1038/s41388-020-01459-w REVIEW ARTICLE Core transcriptional regulatory circuitries in cancer 1 1,2,3 1 2 1,4,5 Ye Chen ● Liang Xu ● Ruby Yu-Tong Lin ● Markus Müschen ● H. Phillip Koeffler Received: 14 June 2020 / Revised: 30 August 2020 / Accepted: 4 September 2020 / Published online: 17 September 2020 © The Author(s) 2020. This article is published with open access Abstract Transcription factors (TFs) coordinate the on-and-off states of gene expression typically in a combinatorial fashion. Studies from embryonic stem cells and other cell types have revealed that a clique of self-regulated core TFs control cell identity and cell state. These core TFs form interconnected feed-forward transcriptional loops to establish and reinforce the cell-type- specific gene-expression program; the ensemble of core TFs and their regulatory loops constitutes core transcriptional regulatory circuitry (CRC). Here, we summarize recent progress in computational reconstitution and biologic exploration of CRCs across various human malignancies, and consolidate the strategy and methodology for CRC discovery. We also discuss the genetic basis and therapeutic vulnerability of CRC, and highlight new frontiers and future efforts for the study of CRC in cancer. Knowledge of CRC in cancer is fundamental to understanding cancer-specific transcriptional addiction, and should provide important insight to both pathobiology and therapeutics. 1234567890();,: 1234567890();,: Introduction genes. Till now, one critical goal in biology remains to understand the composition and hierarchy of transcriptional Transcriptional regulation is one of the fundamental mole- regulatory network in each specified cell type/lineage.
    [Show full text]
  • Identifying and Mapping Cell-Type-Specific Chromatin PNAS PLUS Programming of Gene Expression
    Identifying and mapping cell-type-specific chromatin PNAS PLUS programming of gene expression Troels T. Marstranda and John D. Storeya,b,1 aLewis-Sigler Institute for Integrative Genomics, and bDepartment of Molecular Biology, Princeton University, Princeton, NJ 08544 Edited by Wing Hung Wong, Stanford University, Stanford, CA, and approved January 2, 2014 (received for review July 2, 2013) A problem of substantial interest is to systematically map variation Relating DHS to gene-expression levels across multiple cell in chromatin structure to gene-expression regulation across con- types is challenging because the DHS represents a continuous ditions, environments, or differentiated cell types. We developed variable along the genome not bound to any specific region, and and applied a quantitative framework for determining the exis- the relationship between DHS and gene expression is largely tence, strength, and type of relationship between high-resolution uncharacterized. To exploit variation across cell types and test chromatin structure in terms of DNaseI hypersensitivity and genome- for cell-type-specific relationships between DHS and gene expres- wide gene-expression levels in 20 diverse human cell types. We sion, the measurement units must be placed on a common scale, show that ∼25% of genes show cell-type-specific expression ex- the continuous DHS measure associated to each gene in a well- plained by alterations in chromatin structure. We find that distal defined manner, and all measurements considered simultaneously. regions of chromatin structure (e.g., ±200 kb) capture more genes Moreover, the chromatin and gene-expression relationship may with this relationship than local regions (e.g., ±2.5 kb), yet the local only manifest in a single cell type, making standard measures of regions show a more pronounced effect.
    [Show full text]
  • Establishing the Pathogenicity of Novel Mitochondrial DNA Sequence Variations: a Cell and Molecular Biology Approach
    Mafalda Rita Avó Bacalhau Establishing the Pathogenicity of Novel Mitochondrial DNA Sequence Variations: a Cell and Molecular Biology Approach Tese de doutoramento do Programa de Doutoramento em Ciências da Saúde, ramo de Ciências Biomédicas, orientada pela Professora Doutora Maria Manuela Monteiro Grazina e co-orientada pelo Professor Doutor Henrique Manuel Paixão dos Santos Girão e pela Professora Doutora Lee-Jun C. Wong e apresentada à Faculdade de Medicina da Universidade de Coimbra Julho 2017 Faculty of Medicine Establishing the pathogenicity of novel mitochondrial DNA sequence variations: a cell and molecular biology approach Mafalda Rita Avó Bacalhau Tese de doutoramento do programa em Ciências da Saúde, ramo de Ciências Biomédicas, realizada sob a orientação científica da Professora Doutora Maria Manuela Monteiro Grazina; e co-orientação do Professor Doutor Henrique Manuel Paixão dos Santos Girão e da Professora Doutora Lee-Jun C. Wong, apresentada à Faculdade de Medicina da Universidade de Coimbra. Julho, 2017 Copyright© Mafalda Bacalhau e Manuela Grazina, 2017 Esta cópia da tese é fornecida na condição de que quem a consulta reconhece que os direitos de autor são pertença do autor da tese e do orientador científico e que nenhuma citação ou informação obtida a partir dela pode ser publicada sem a referência apropriada e autorização. This copy of the thesis has been supplied on the condition that anyone who consults it recognizes that its copyright belongs to its author and scientific supervisor and that no quotation from the
    [Show full text]
  • Detailed Review Paper on Retinoid Pathway Signalling
    1 1 Detailed Review Paper on Retinoid Pathway Signalling 2 December 2020 3 2 4 Foreword 5 1. Project 4.97 to develop a Detailed Review Paper (DRP) on the Retinoid System 6 was added to the Test Guidelines Programme work plan in 2015. The project was 7 originally proposed by Sweden and the European Commission later joined the project as 8 a co-lead. In 2019, the OECD Secretariat was added to coordinate input from expert 9 consultants. The initial objectives of the project were to: 10 draft a review of the biology of retinoid signalling pathway, 11 describe retinoid-mediated effects on various organ systems, 12 identify relevant retinoid in vitro and ex vivo assays that measure mechanistic 13 effects of chemicals for development, and 14 Identify in vivo endpoints that could be added to existing test guidelines to 15 identify chemical effects on retinoid pathway signalling. 16 2. This DRP is intended to expand the recommendations for the retinoid pathway 17 included in the OECD Detailed Review Paper on the State of the Science on Novel In 18 vitro and In vivo Screening and Testing Methods and Endpoints for Evaluating 19 Endocrine Disruptors (DRP No 178). The retinoid signalling pathway was one of seven 20 endocrine pathways considered to be susceptible to environmental endocrine disruption 21 and for which relevant endpoints could be measured in new or existing OECD Test 22 Guidelines for evaluating endocrine disruption. Due to the complexity of retinoid 23 signalling across multiple organ systems, this effort was foreseen as a multi-step process.
    [Show full text]
  • Pitx3 KNOCKOUT MICE ENTRAIN to SCHEDULED FEEDING DESPITE
    Pitx3 KNOCKOUT MICE ENTRAIN TO SCHEDULED FEEDING DESPITE FREE-RUNNING LIGHT ENTRAINED RHYTHMS A Thesis Presented to the Faculty of California State Polytechnic University, Pomona In Partial Fulfillment Of the Requirements for the Degree Master of Science In Biological Sciences By Lori L. Scarpa 2019 SIGNATURE PAGE THESIS: Pitx3 KNOCKOUT MICE ENTRAIN TO SCHEDULED FEEINDING DESPITE FREE-RUNNING LIGHT ENTRAINED RHYTHMS AUTHOR: Lori L. Scarpa DATE SUBMITTED: Fall 2019 Department of Biological Sciences Dr. Andrew D. Steele Thesis Committee Chair Biological Sciences Dr. Juanita Jellyman Biological Sciences Dr. Robert Talmadge Biological Sciences ii ACKNOWLEDGEMENTS Funding for this project was provided by the Whitehall Foundation and California State Polytechnic University of Pomona, California. I would like to thank the many people who assisted in the daily labors required to complete this project: Raymundo Miranda, Michael Sidikpramana, Jeffrey Falkenstein, Michael Williams, Jaskaran Dhanoa, and many other members of the Steele lab. I would like to specially recognize fellow graduate students in the Steele lab, Damien Wolfe and Andrew Villa, for their unconditional encouragement and support. I would like to thank Dr. Juanita Jellyman for her kindness and nurturing spirit. Dr. Jellyman never wavered her belief in me and it was this that kept me working harder towards my goals. Lastly, I would like thank Dr. Andrew Steele for accepting me into his lab, for being my personal mentor, and for pushing me towards success. Through him, I have grown to become a better scientist and found greater inspiration in my pursuit to further study neuroscience. Thank you, Dr. Steele, for your support and patience, and for playing a leading role in my success as a graduate student in your lab.
    [Show full text]
  • Table S1 the Four Gene Sets Derived from Gene Expression Profiles of Escs and Differentiated Cells
    Table S1 The four gene sets derived from gene expression profiles of ESCs and differentiated cells Uniform High Uniform Low ES Up ES Down EntrezID GeneSymbol EntrezID GeneSymbol EntrezID GeneSymbol EntrezID GeneSymbol 269261 Rpl12 11354 Abpa 68239 Krt42 15132 Hbb-bh1 67891 Rpl4 11537 Cfd 26380 Esrrb 15126 Hba-x 55949 Eef1b2 11698 Ambn 73703 Dppa2 15111 Hand2 18148 Npm1 11730 Ang3 67374 Jam2 65255 Asb4 67427 Rps20 11731 Ang2 22702 Zfp42 17292 Mesp1 15481 Hspa8 11807 Apoa2 58865 Tdh 19737 Rgs5 100041686 LOC100041686 11814 Apoc3 26388 Ifi202b 225518 Prdm6 11983 Atpif1 11945 Atp4b 11614 Nr0b1 20378 Frzb 19241 Tmsb4x 12007 Azgp1 76815 Calcoco2 12767 Cxcr4 20116 Rps8 12044 Bcl2a1a 219132 D14Ertd668e 103889 Hoxb2 20103 Rps5 12047 Bcl2a1d 381411 Gm1967 17701 Msx1 14694 Gnb2l1 12049 Bcl2l10 20899 Stra8 23796 Aplnr 19941 Rpl26 12096 Bglap1 78625 1700061G19Rik 12627 Cfc1 12070 Ngfrap1 12097 Bglap2 21816 Tgm1 12622 Cer1 19989 Rpl7 12267 C3ar1 67405 Nts 21385 Tbx2 19896 Rpl10a 12279 C9 435337 EG435337 56720 Tdo2 20044 Rps14 12391 Cav3 545913 Zscan4d 16869 Lhx1 19175 Psmb6 12409 Cbr2 244448 Triml1 22253 Unc5c 22627 Ywhae 12477 Ctla4 69134 2200001I15Rik 14174 Fgf3 19951 Rpl32 12523 Cd84 66065 Hsd17b14 16542 Kdr 66152 1110020P15Rik 12524 Cd86 81879 Tcfcp2l1 15122 Hba-a1 66489 Rpl35 12640 Cga 17907 Mylpf 15414 Hoxb6 15519 Hsp90aa1 12642 Ch25h 26424 Nr5a2 210530 Leprel1 66483 Rpl36al 12655 Chi3l3 83560 Tex14 12338 Capn6 27370 Rps26 12796 Camp 17450 Morc1 20671 Sox17 66576 Uqcrh 12869 Cox8b 79455 Pdcl2 20613 Snai1 22154 Tubb5 12959 Cryba4 231821 Centa1 17897
    [Show full text]
  • Stelios Pavlidis3, Matthew Loza3, Fred Baribaud3, Anthony
    Supplementary Data Th2 and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in UBIOPRED Chih-Hsi Scott Kuo1.2, Stelios Pavlidis3, Matthew Loza3, Fred Baribaud3, Anthony Rowe3, Iaonnis Pandis2, Ana Sousa4, Julie Corfield5, Ratko Djukanovic6, Rene 7 7 8 2 1† Lutter , Peter J. Sterk , Charles Auffray , Yike Guo , Ian M. Adcock & Kian Fan 1†* # Chung on behalf of the U-BIOPRED consortium project team 1Airways Disease, National Heart & Lung Institute, Imperial College London, & Biomedical Research Unit, Biomedical Research Unit, Royal Brompton & Harefield NHS Trust, London, United Kingdom; 2Department of Computing & Data Science Institute, Imperial College London, United Kingdom; 3Janssen Research and Development, High Wycombe, Buckinghamshire, United Kingdom; 4Respiratory Therapeutic Unit, GSK, Stockley Park, United Kingdom; 5AstraZeneca R&D Molndal, Sweden and Areteva R&D, Nottingham, United Kingdom; 6Faculty of Medicine, Southampton University, Southampton, United Kingdom; 7Faculty of Medicine, University of Amsterdam, Amsterdam, Netherlands; 8European Institute for Systems Biology and Medicine, CNRS-ENS-UCBL, Université de Lyon, France. †Contributed equally #Consortium project team members are listed under Supplementary 1 Materials *To whom correspondence should be addressed: [email protected] 2 List of the U-BIOPRED Consortium project team members Uruj Hoda & Christos Rossios, Airways Disease, National Heart & Lung Institute, Imperial College London, UK & Biomedical Research Unit, Biomedical Research Unit, Royal
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Mathematical Modeling of Noise and Discovery of Genetic Expression Classes in Gliomas
    Oncogene (2002) 21, 7164 – 7174 ª 2002 Nature Publishing Group All rights reserved 0950 – 9232/02 $25.00 www.nature.com/onc Mathematical modeling of noise and discovery of genetic expression classes in gliomas Hassan M Fathallah-Shaykh*,1, Mo Rigen1, Li-Juan Zhao1, Kanti Bansal1, Bin He1, Herbert H Engelhard3, Leonard Cerullo2, Kelvin Von Roenn2, Richard Byrne2, Lorenzo Munoz2, Gail L Rosseau2, Roberta Glick4, Terry Lichtor4 and Elia DiSavino1 1Department of Neurological Sciences, Rush Presbyterian – St. Lukes Medical Center, Chicago, Illinois, IL 60612, USA; 2Department of Neurosurgery, Rush Presbyterian – St. Lukes Medical Center, Chicago, Illinois, IL 60612, USA; 3Department of Neurosurgery, The University of Illinois at Chicago, Chicago, Illinois, IL 60612, USA; 4Department of Neurosurgery, The Cook County Hospital, Chicago, Illinois, IL 60612, USA The microarray array experimental system generates genetic repertoire in any disease-affected tissue. noisy data that require validation by other experimental However, genome-wide screening is still hampered by methods for measuring gene expression. Here we present the preponderance of false positive data in the gene an algebraic modeling of noise that extracts expression microarray experimental system (Ting Lee et al., 2000). measurements true to a high degree of confidence. This The following experiments are designed to profile the work profiles the expression of 19 200 cDNAs in 35 expression of 19 200 cDNAs in 35 human glioma human gliomas; the experiments are designed to generate samples. Here, we apply mathematical principles to four replicate spots/gene with switching of probes. The separate the noise and extract genes whose expression validity of the extracted measurements is confirmed by: levels are considered truly changed, to a high degree of (1) cluster analysis that generates a molecular classifica- confidence, in the tumor samples as compared to tion differentiating glioblastoma from lower-grade tumors normal brain.
    [Show full text]
  • Tyson Goldberg Et Al-2015-Development-1267-78
    © 2015. Published by The Company of Biologists Ltd | Development (2015) 142, 1267-1278 doi:10.1242/dev.111526 RESEARCH ARTICLE STEM CELLS AND REGENERATION Duration of culture and sonic hedgehog signaling differentially specify PV versus SST cortical interneuron fates from embryonic stem cells Jennifer A. Tyson1,2, Ethan M. Goldberg3,4, Asif M. Maroof5, Qing Xu6, Timothy J. Petros7 and Stewart A. Anderson1,* ABSTRACT dysfunction is associated with a variety of neurological diseases, Medial ganglionic eminence (MGE)-derived GABAergic cortical including seizure disorders, schizophrenia and autism (Belforte et al., interneurons (cINs) consist of multiple subtypes that are involved in 2010; Chao et al., 2010; Inan et al., 2013). Interneurons are classified many cortical functions. They also have a remarkable capacity to into functionally distinct subgroups based on neurochemical markers, migrate, survive and integrate into cortical circuitry after transplantation connectivity profiles and electrophysiological properties (DeFelipe into postnatal cortex. These features have engendered considerable et al., 2013), with specific subtypes being implicated in different interest in generating distinct subgroups of interneurons from pluripotent disease etiologies (Binaschi et al., 2003; Levitt et al., 2004; Inan et al., stem cells (PSCs) for the study of interneuron fate and function, and for 2013; Jiang et al., 2013; Smith-Hicks, 2013). Genetic fate mapping the development of cell-based therapies. Although advances have been and transplantation studies
    [Show full text]